New Study Reveals Association Between Nrf2, Oxidative Stress, Aging and Healing

PRWEB reports a new study conducted by Nutri-Med Logic Corp in which they found that improper NRF2 activation within the body's cells results in premature aging of the blood vessels called Angiogenesis. The study also highlights the improper healing of damaged vessels.. The company report that "Nrf2, also known as a physiological regulator of oxidative stress (free radical damage), plays an important part in general premature aging as well as many diseases, ranging from Arthritis to Alzheimer's." 


 


PRWEB reports a new study conducted by Nutri-Med Logic Corp in which they found that improper NRF2 activation within the body's cells results in premature aging of the blood vessels called Angiogenesis. The study also highlights the improper healing of damaged vessels.. The company report that "Nrf2, also known as a physiological regulator of oxidative stress (free radical damage), plays an important part in general premature aging as well as many diseases, ranging from Arthritis to Alzheimer's." 

Separately, Glutathione, SOD, and Catalase are three of hundreds of genes known as survival genes. Research shows that as one age the body is less able to manufacture its own survival antioxidants. This results in aging. There are ten peer-reviewed studies published on Pubmed.gov for a supplement known as Protantim which is a NRF2 activator. This supplement has been shown to rev up the body's own production of NRF2 through the NRF2 Pathway, within as little as 2 weeks.

Augusta University Discovers How Nrf2 Activator Preserves Sight in Retinal Degeneration Model
New Protandim Study – International Formula Impact on Oxidative Stress
Reversal of persistent fibrosis in aging by targeting nox4-Nrf2 redox imbalance – Sciencemag.org
Inflammation: A Major Contributor to Disease and Aging. Can Nrf2 Help Reduce It?
Spring Cleaning Damaged Proteins with Nrf2: Good for Huntington’s Disease and Other Neurodegenerative Disorders?
New Grant Issued for Nrf2 and Epilepsy Prevention Study